Thalamic Damage Predicts the Evolution of Primary-Progressive Multiple Sclerosis at 5 Years

References

1. 1.↵
   1. Thompson AJ,
   2. Montalban X,
   3. Barkhof F,
   4. et al

   . Diagnostic criteria for primary progressive multiple sclerosis: a position paper. Ann Neurol 2000; 47: 831– 35

   CrossRefPubMedWeb of Science
2. 2.↵
   1. Miller DH,
   2. Leary SM

   . Primary-progressive multiple sclerosis. Lancet Neurol 2007; 6: 903– 12

   CrossRefPubMedWeb of Science
3. 3.↵
   1. Rovaris M,
   2. Bozzali M,
   3. Santuccio G,
   4. et al

   . In vivo assessment of the brain and cervical cord pathology of patients with primary progressive multiple sclerosis. Brain 2001; 124: 2540– 49

   Abstract/FREE Full Text
4. 4.↵
   1. Rovaris M,
   2. Bozzali M,
   3. Iannucci G,
   4. et al

   . Assessment of normal-appearing white and gray matter in patients with primary progressive multiple sclerosis: a diffusion-tensor magnetic resonance imaging study. Arch Neurol 2002; 59: 1406– 12

   CrossRefPubMedWeb of Science
5. 5.↵
   1. Rovaris M,
   2. Gallo A,
   3. Falini A,
   4. et al

   . Axonal injury and overall tissue loss are not related in primary progressive multiple sclerosis. Arch Neurol 2005; 62: 898– 902

   CrossRefPubMedWeb of Science
6. 6.↵
   1. Rovaris M,
   2. Gallo A,
   3. Valsasina P,
   4. et al

   . Short-term accrual of gray matter pathology in patients with progressive multiple sclerosis: an in vivo study using diffusion tensor MRI. Neuroimage 2005; 24: 1139– 46

   CrossRefPubMedWeb of Science
7. 7.↵
   1. Sastre-Garriga J,
   2. Ingle GT,
   3. Chard DT,
   4. et al

   . Grey and white matter volume changes in early primary progressive multiple sclerosis: a longitudinal study. Brain 2005; 128: 1454– 60

   Abstract/FREE Full Text
8. 8.↵
   1. Manfredonia F,
   2. Ciccarelli O,
   3. Khaleeli Z,
   4. et al

   . Normal-appearing brain T1 relaxation time predicts disability in early primary progressive multiple sclerosis. Arch Neurol 2007; 64: 411– 15

   CrossRefPubMed
9. 9.↵
   1. Ceccarelli A,
   2. Rocca MA,
   3. Valsasina P,
   4. et al

   . A multiparametric evaluation of regional brain damage in patients with primary progressive multiple sclerosis. Hum Brain Mapp 2009; 30: 3009– 19

   CrossRefPubMedWeb of Science
10. 10.↵
    1. Calabrese M,
    2. Rocca MA,
    3. Atzori M,
    4. et al

    . Cortical lesions in primary progressive multiple sclerosis: a 2-year longitudinal MR study. Neurology 2009; 72: 1330– 36

    Abstract/FREE Full Text
11. 11.↵
    1. Rovaris M,
    2. Judica E,
    3. Gallo A,
    4. et al

    . Grey matter damage predicts the evolution of primary progressive multiple sclerosis at 5 years. Brain 2006; 129: 2628– 34

    Abstract/FREE Full Text
12. 12.↵
    1. Khaleeli Z,
    2. Ciccarelli O,
    3. Manfredonia F,
    4. et al

    . Predicting progression in primary progressive multiple sclerosis: a 10-year multicenter study. Ann Neurol 2008; 63: 790– 93

    CrossRefPubMedWeb of Science
13. 13.↵
    1. Cifelli A,
    2. Arridge M,
    3. Jezzard P,
    4. et al

    . Thalamic neurodegeneration in multiple sclerosis. Ann Neurol 2002; 52: 650– 53

    CrossRefPubMedWeb of Science
14. 14.↵
    1. Vercellino M,
    2. Masera S,
    3. Lorenzatti M,
    4. et al

    . Demyelination, inflammation, and neurodegeneration in multiple sclerosis deep gray matter. J Neuropathol Exp Neurol 2009; 68: 489– 502

    CrossRefPubMedWeb of Science
15. 15.↵
    1. Ormerod IE,
    2. Miller DH,
    3. McDonald WI,
    4. et al

    . The role of NMR imaging in the assessment of multiple sclerosis and isolated neurological lesions: a quantitative study. Brain 1987; 110 (pt 6): 1579– 616

    Abstract/FREE Full Text
16. 16.↵
    1. Fabiano AJ,
    2. Sharma J,
    3. Weinstock-Guttman B,
    4. et al

    . Thalamic involvement in multiple sclerosis: a diffusion-weighted magnetic resonance imaging study. J Neuroimaging 2003; 13: 307– 14

    CrossRefPubMedWeb of Science
17. 17.↵
    1. Ciccarelli O,
    2. Werring DJ,
    3. Wheeler-Kingshott CA,
    4. et al

    . Investigation of MS normal-appearing brain using diffusion tensor MRI with clinical correlations. Neurology 2001; 56: 926– 33

    Abstract/FREE Full Text
18. 18.↵
    1. Wylezinska M,
    2. Cifelli A,
    3. Jezzard P,
    4. et al

    . Thalamic neurodegeneration in relapsing-remitting multiple sclerosis. Neurology 2003; 60: 1949– 54

    Abstract/FREE Full Text
19. 19.↵
    1. Inglese M,
    2. Liu S,
    3. Babb JS,
    4. et al

    . Three-dimensional proton spectroscopy of deep gray matter nuclei in relapsing-remitting MS. Neurology 2004; 63: 170– 72

    Abstract/FREE Full Text
20. 20.↵
    1. Henry RG,
    2. Shieh M,
    3. Okuda DT,
    4. et al

    . Regional grey matter atrophy in clinically isolated syndromes at presentation. J Neurol Neurosurg Psychiatry 2008; 79: 1236– 44

    Abstract/FREE Full Text
21. 21.↵
    1. Mesaros S,
    2. Rocca MA,
    3. Absinta M,
    4. et al

    . Evidence of thalamic gray matter loss in pediatric multiple sclerosis. Neurology 2008; 70: 1107– 12

    Abstract/FREE Full Text
22. 22.↵
    1. Audoin B,
    2. Davies GR,
    3. Finisku L,
    4. et al

    . Localization of grey matter atrophy in early RRMS: a longitudinal study. J Neurol 2006; 253: 1495– 501

    CrossRefPubMedWeb of Science
23. 23.↵
    1. Sepulcre J,
    2. Sastre-Garriga J,
    3. Cercignani M,
    4. et al

    . Regional gray matter atrophy in early primary progressive multiple sclerosis: a voxel-based morphometry study. Arch Neurol 2006; 63: 1175– 80

    CrossRefPubMedWeb of Science
24. 24.↵
    1. Kurtzke JF

    . Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33: 1444– 52

    Abstract/FREE Full Text
25. 25.↵
    1. Miller DH,
    2. Barkhof F,
    3. Berry I,
    4. et al

    . Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines. J Neurol Neurosurg Psychiatry 1991; 54: 683– 88

    Abstract/FREE Full Text
26. 26.↵
    1. Rovaris M,
    2. Filippi M,
    3. Calori G,
    4. et al

    . Intra-observer reproducibility in measuring new putative MR markers of demyelination and axonal loss in multiple sclerosis: a comparison with conventional T2-weighted images. J Neurol 1997; 244: 266– 70

    CrossRefPubMedWeb of Science
27. 27.↵
    1. Smith SM,
    2. Zhang Y,
    3. Jenkinson M,
    4. et al

    . Accurate, robust, and automated longitudinal and cross-sectional brain change analysis. Neuroimage 2002; 17: 479– 89

    CrossRefPubMedWeb of Science
28. 28.↵
    1. Smith SM,
    2. De Stefano N,
    3. Jenkinson M,
    4. et al

    . Normalized accurate measurement of longitudinal brain change. J Comput Assist Tomogr 2001; 25: 466– 75

    CrossRefPubMedWeb of Science
29. 29.↵
    1. Rocca MA,
    2. Mesaros S,
    3. Pagani E,
    4. et al

    . Thalamic damage and long-term progression of disability in multiple sclerosis. Radiology 2010; 257: 463– 69

    CrossRefPubMedWeb of Science
30. 30.↵
    1. Khaleeli Z,
    2. Cercignani M,
    3. Audoin B,
    4. et al

    . Localized grey matter damage in early primary progressive multiple sclerosis contributes to disability. Neuroimage 2007; 37: 253– 61

    CrossRefPubMedWeb of Science
31. 31.↵
    1. Tovar-Moll F,
    2. Evangelou IE,
    3. Chiu AW,
    4. et al

    . Thalamic involvement and its impact on clinical disability in patients with multiple sclerosis: a diffusion tensor imaging study at 3T. AJNR Am J Neuroradiol 2009; 30: 1380– 86

    Abstract/FREE Full Text
32. 32.↵
    1. Rose SE,
    2. Janke AL,
    3. Chalk JB

    . Gray and white matter changes in Alzheimer's disease: a diffusion tensor imaging study. J Magn Reson Imaging 2008; 27: 20– 26

    CrossRefPubMedWeb of Science
33. 33.↵
    1. Sach M,
    2. Winkler G,
    3. Glauche V,
    4. et al

    . Diffusion tensor MRI of early upper motor neuron involvement in amyotrophic lateral sclerosis. Brain 2004; 127: 340– 50

    Abstract/FREE Full Text
34. 34.↵
    1. Bodini B,
    2. Khaleeli Z,
    3. Cercignani M,
    4. et al

    . Exploring the relationship between white matter and gray matter damage in early primary progressive multiple sclerosis: an in vivo study with TBSS and VBM. Hum Brain Mapp 2009; 30: 2852– 61

    CrossRefPubMedWeb of Science
35. 35.↵
    1. Penny S,
    2. Khaleeli Z,
    3. Cipolotti L,
    4. et al

    . Early imaging predicts later cognitive impairment in primary progressive multiple sclerosis. Neurology 2010; 74: 545– 52

    Abstract/FREE Full Text
36. 36.↵
    1. Kutzelnigg A,
    2. Lucchinetti CF,
    3. Stadelmann C,
    4. et al

    . Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 2005; 128: 2705– 12

    Abstract/FREE Full Text